Sugai J - Search Results

1

Effects of maxacalcitol ointment on skin lesions in patients with psoriasis receiving treatment with adalimumab.

Karakawa M, Komine M, Kishimoto M, Maki N, Matsumoto A, Sugai J, Ohtsuki M. Karakawa M, et al. Among authors: sugai j. J Dermatol. 2016 Nov;43(11):1354-1357. doi: 10.1111/1346-8138.13515. Epub 2016 Jul 23. J Dermatol. 2016. PMID: 27450634 Clinical Trial.

2

Real-world use of apremilast for patients with psoriasis in Japan.

Kishimoto M, Komine M, Hioki T, Kamiya K, Sugai J, Ohtsuki M. Kishimoto M, et al. Among authors: sugai j. J Dermatol. 2018 Nov;45(11):1345-1348. doi: 10.1111/1346-8138.14617. Epub 2018 Aug 31. J Dermatol. 2018. PMID: 30168880

3

Results of a retrospective study on the efficacy and safety of adalimumab 80 mg administrated every other week in patients with psoriasis at a single Japanese institution.

Kamiya K, Karakawa M, Komine M, Kishimoto M, Sugai J, Ohtsuki M. Kamiya K, et al. Among authors: sugai j. J Dermatol. 2019 Mar;46(3):199-205. doi: 10.1111/1346-8138.14782. Epub 2019 Jan 23. J Dermatol. 2019. PMID: 30672612

4

Drug survival of apremilast in a real-world setting.

Kishimoto M, Komine M, Kamiya K, Sugai J, Ohtsuki M. Kishimoto M, et al. Among authors: sugai j. J Dermatol. 2019 Jul;46(7):615-617. doi: 10.1111/1346-8138.14943. Epub 2019 Jun 10. J Dermatol. 2019. PMID: 31180150

5

Drug survival of biologic agents for psoriatic patients in a real-world setting in Japan.

Kishimoto M, Komine M, Kamiya K, Sugai J, Mieno M, Ohtsuki M. Kishimoto M, et al. Among authors: sugai j. J Dermatol. 2020 Jan;47(1):33-40. doi: 10.1111/1346-8138.15146. Epub 2019 Nov 6. J Dermatol. 2020. PMID: 31696543

6

Single-center survey of biologic use for inflammatory skin diseases during the coronavirus disease 2019 pandemic.

Kado S, Kamiya K, Kishimoto M, Maekawa T, Kuwahara A, Sugai J, Komine M, Ohtsuki M. Kado S, et al. Among authors: sugai j. J Dermatol. 2021 Dec;48(12):1907-1912. doi: 10.1111/1346-8138.16159. Epub 2021 Sep 21. J Dermatol. 2021. PMID: 34549456 Free PMC article.

7

Case of psoriasis with hepatitis B virus infection during tumor necrosis factor inhibitor treatment successfully treated with ixekizumab and tenofovir alafenamide fumarate.

Kishimoto M, Komine M, Kamiya K, Sugai J, Kuwahara A, Morimoto N, Ohtsuki M. Kishimoto M, et al. Among authors: sugai j. J Dermatol. 2022 Jun;49(6):e193-e194. doi: 10.1111/1346-8138.16320. Epub 2022 Feb 20. J Dermatol. 2022. PMID: 35187727 No abstract available.

8

Long-term continuous versus intermittent cyclosporin: therapy for psoriasis.

Ohtsuki M, Nakagawa H, Sugai J, Ozawa A, Ohkido M, Nakayama J, Hanada J, Morimoto Y, Jimbow K, Horikoshi T, Kitahara H, Tamaki K, Urabe K, Hori Y. Ohtsuki M, et al. Among authors: sugai j. J Dermatol. 2003 Apr;30(4):290-8. doi: 10.1111/j.1346-8138.2003.tb00390.x. J Dermatol. 2003. PMID: 12707465 Clinical Trial.

9

Risk Factors for the Development of Psoriasis.

Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Kamiya K, et al. Among authors: sugai j. Int J Mol Sci. 2019 Sep 5;20(18):4347. doi: 10.3390/ijms20184347. Int J Mol Sci. 2019. PMID: 31491865 Free PMC article. Review.

10

STAT3 Activation in Psoriasis and Cancers.

Kishimoto M, Komine M, Sashikawa-Kimura M, Ansary TM, Kamiya K, Sugai J, Mieno M, Kawata H, Sekimoto R, Fukushima N, Ohtsuki M. Kishimoto M, et al. Among authors: sugai j. Diagnostics (Basel). 2021 Oct 15;11(10):1903. doi: 10.3390/diagnostics11101903. Diagnostics (Basel). 2021. PMID: 34679602 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page